What Is Semax?
Semax (ACTH(4-7)-PGP) is classified as a cognitive peptide peptide. BDNF upregulation, nootropic effects. Enhances neural plasticity, protects neurons from oxidative stress, and improves cerebral blood circulation.
It is extensively evaluated in laboratory and clinical settings for its potential to drive mental clarity, focus, neuroprotection. Researchers target Semax for its ability to interact with specific cellular and molecular pathways, making it a compound of significant interest across multiple therapeutic domains.
Nasal spray common; well-tolerated. Approved in Russia/Ukraine. Not FDA-approved in the US.
How Does Semax Work?
BDNF upregulation, nootropic effects. Enhances neural plasticity, protects neurons from oxidative stress, and improves cerebral blood circulation.
At the molecular level, Semax operates through pathways characteristic of the Cognitive Peptide class. By interacting with target receptors and downstream signaling cascades, the compound initiates biological responses associated with mental clarity, focus, neuroprotection.
Expected Research Timeline
Weeks 2–4
BDNF-mediated improvements in memory consolidation and mood stability
Months 2–3
Neuroprotective adaptation; reduced cognitive fatigue under stress
Long-Term
Sustained cognitive baseline improvement; may support neurogenesis
What Does the Research Say?
The following are key findings from peer-reviewed studies on Semax, indexed on PubMed and equivalent databases:
[1]Semax cognitive improvement in humans
Human trial showing cognitive improvement including enhanced attention, memory formation, and learning capacity.
Evidence: moderate[2]Semax increases BDNF and TrkB expression in hippocampus
Dolotov et al. demonstrate Semax significantly upregulates BDNF and its receptor TrkB in the rat hippocampus, providing mechanistic basis for its nootropic effects.
Evidence: preclinical[3]Semax high efficacy in acute ischemic stroke
Clinical-electrophysiologic studies report high efficacy of Semax in acute ischemic stroke patients, with significant neuroprotective effects and improved functional recovery.
Evidence: moderate strong[4]Semax modulates neurotrophin gene expression (NGF, BDNF)
Molecular study showing Semax modulates expression of multiple neurotrophin genes including BDNF and nerve growth factor, supporting its broad neuroprotective mechanism.
Evidence: preclinical[5]Semax effects on brain functional connectivity (fMRI)
fMRI study in healthy individuals demonstrates Semax modulates brain functional connectivity networks, providing imaging evidence for its nootropic effects.
Evidence: moderateSafety & Side Effects
Nasal spray common; well-tolerated. Approved in Russia/Ukraine. Not FDA-approved in the US.
| Side Effect | Incidence | Severity |
|---|---|---|
| Nasal irritation | ~8% of users | mild |
| Mild headache | ~5% of users | mild |
| Irritability at high doses | ~3% of users | mild |
FDA Status: Not Approved for Human Therapeutic Use
Semax is not currently FDA-approved for human use. It is available for research purposes only. Always consult a licensed healthcare provider.
How Is Semax Used?
Route
Nasal
Dose Range
300–300 mcg
Frequency
7x/wk
Cycle
8–8 wk
Timing: Morning
Notes: Nasal spray: 1-2 sprays per nostril. Can cycle 5 days on/2 off.
All dosing information reflects parameters reported in published research literature and is not intended as clinical guidance. Usage of any peptide should be supervised by a qualified healthcare professional.
Semax vs. Related Compounds
| Compound | Primary Use |
|---|---|
| Semax(this page) | Mental clarity, focus, neuroprotection |
| Selank | Anxiety reduction, mental clarity, mood |
Where to Source Semax for Research
Purchasing ultra-high purity, laboratory-grade peptides is critical for verifiable research. We only recommend vendors providing independent, third-party HPLC Certificates of Analysis (COA).
Disclosure: PeptiDex may earn a commission from purchases. This does not affect our recommendations. We exclusively feature vendors that pass our strict quality verification protocols.
Frequently Asked Questions
What is Semax?
Semax is a cognitive peptide peptide. BDNF upregulation, nootropic effects. Enhances neural plasticity, protects neurons from oxidative stress, and improves cerebral blood circulation.
What are the primary research benefits of Semax?
Published research identifies primary mechanisms targeting: Mental clarity, focus, neuroprotection. These findings come from 5+ peer-reviewed studies indexed in our database.
What is the half-life of Semax?
In published pharmacokinetic data, Semax demonstrates a half-life of approximately 0.33 hours.
Is Semax FDA approved?
Semax is not currently FDA-approved for human therapeutic use. It is classified as a research compound and is studied under investigational protocols. Always consult a healthcare provider.
What are common side effects of Semax?
Reported side effects in published literature include Nasal irritation (~8% of users), Mild headache (~5% of users), Irritability at high doses (~3% of users). Most are classified as mild in severity.
How is Semax administered?
In research settings, Semax is typically administered via Nasal. Nasal spray: 1-2 sprays per nostril. Can cycle 5 days on/2 off.
Sources
- Semax cognitive improvement in humans. View on PubMed
- Semax increases BDNF and TrkB expression in hippocampus. View on PubMed
- Semax high efficacy in acute ischemic stroke. View on PubMed
- Semax modulates neurotrophin gene expression (NGF, BDNF). View on PubMed
- Semax effects on brain functional connectivity (fMRI). View on PubMed